Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer
Clinical trial NCT00915603 · COMPLETED
Trial details
- NCT number
- NCT00915603
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2014-06-01
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.